No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
ANVS Annovis Bio
- 6.650
- -0.640-8.78%
Close May 28 16:00 ET
- 7.000
- +0.350+5.26%
Post 17:41 ET
74.29MMarket Cap-1154P/E (TTM)
7.467High6.430Low330.51KVolume7.400Open7.290Pre Close2.24MTurnover3.96%Turnover RatioLossP/E (Static)11.17MShares22.49052wk High-22.17P/B55.54MFloat Cap4.79052wk Low--Dividend TTM8.35MShs Float132.000Historical High--Div YieldTTM14.23%Amplitude2.418Historical Low6.766Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Annovis Announces New Publication in a Peer-Reviewed Journal
Tue, 21 May 2024MALVERN, Pa., May 21, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-stage drug platform company developing novel therapies for neur
Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC
Biocryst Pharmaceuticals, T2 Biosystems, Annovis Bio Among Healthcare Movers
Buy Rating Maintained for Annovis Bio Ahead of Key Parkinson's Drug Trial Results
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
Stocks With More Than 10% Short Interest - Finviz Screener
Comments
$Annovis Bio(ANVS.US$
NEWS
Annovis Announces New Publication in a Peer-Reviewed Journal
Annovis has published a new article in Biomolecules focusing on Posiphen's pharmacokinetics across different species. The study provides a comprehensive comparison of Posiphen's absorption and metabolism in mice, rats, dogs, and humans. Key findings include fast peak concentration in the plasma, high brain and CSF absorption, rapid clearance from the system, and prolonged retention in the brain. Posiphen's p...
NEWS
Annovis Announces New Publication in a Peer-Reviewed Journal
Annovis has published a new article in Biomolecules focusing on Posiphen's pharmacokinetics across different species. The study provides a comprehensive comparison of Posiphen's absorption and metabolism in mice, rats, dogs, and humans. Key findings include fast peak concentration in the plasma, high brain and CSF absorption, rapid clearance from the system, and prolonged retention in the brain. Posiphen's p...
3
1
GL to all$Annovis Bio(ANVS.US$ News that the FDA is going to clear their drug. Ran out of shares today. Borrow rate is higher than its ever been. Price movement is indicating reversal. Only 3 resistance points which are 6.20, 6.89, and 7.28.
3
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg